Evidence map›Paper›PMID 27760574›Full record

ArticleEpidemiology and infection2017

Optimal vaccine schedules to maintain measles elimination with a two-dose routine policy.

A McKEE, K Shea, M J Ferrari

Open access · hybridAbstract read
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cost-effectiveness of workplace vaccination against measles.Human vaccines & immunotherapeutics · 2019
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A McKEEDepartment of Biology, Pennsylvania State University, PA, USA.
K SheaDepartment of Biology, Pennsylvania State University, PA, USA.
M J FerrariDepartment of Biology, Pennsylvania State University, PA, USA.
Pennsylvania State University · US

Funding

Linking models and policy: Using active adaptive management for optimal control of disease outbreaksR01GM105247 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI FERRARI, MATTHEW · 2012 to 2016
$1.3M
NIGMS NIH HHS R01 GM105247
6 · The paper itself

Abstract

Measles was eliminated in the Americas in 2002 by a combination of routine immunizations and supplementary immunization activities. Recent outbreaks underscore the importance of reconsidering vaccine policy in order to maintain elimination. We constructed an age-structured dynamical model for the distribution of immunity in a population with routine immunization and without disease, and analysed the steady state for an idealized age structure and for real age structures of countries in the Americas. We compared the level of immunity maintained by current policy in these countries to the level maintainable by an optimal policy. The optimal age target for the first routine dose of measles vaccine depends on the timing and coverage of both doses. Similarly, the optimal age target for the second dose of measles vaccine depends on the timing and coverage of the first dose. The age targets for the first and second doses of measles vaccine should be adjusted for the post-elimination era, by specifically accounting for current context, including realized coverage of both doses, and altered maternal immunity. Doing so can greatly improve the proportion immune within a population, and therefore the chances of maintaining measles elimination, without changing coverage.

Indexed as

Disease EradicationImmunization ScheduleAdolescentAdultAgedAge FactorsAmericasChildChild, PreschoolFemaleHealth PolicyHumansInfantInfant, NewbornMaleMeaslesMeasles VaccineMaintenance of measles eliminationmathematical modellingmeasles (rubeola)vaccination (immunization)vaccine policy development

Identifiers

PMID27760574
PMCPMC5197928
OpenAlexW2537587263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.